EULAR evidence based recommendations for the management of hand osteoarthritis: Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics…
By Weiya Zhang, M. Doherty, B. Leeb, L. Alekseeva, N. Arden, J. Bijlsma, F. DİnÇer, K. Dziedzic, H. Häuselmann, G. Herrero-Beaumont and 11 more. Annals of the Rheumatic Diseases, 2005
1,247 citations recorded by the source corpus.
Subfields: Rheumatology, Surgery
View Paper: https://www.semanticscholar.org/paper/f81f404613e851954ccdd77285aa2a4a2b2e81d8
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Rheumatology
In Surgery
Citations in the corpus
- A systematic review of recommendations and guidelines for the management of osteoarthritis: The chronic osteoarthritis management initiative of the U.S. bone and joint initiative. (2014, methodology): “EULAR-hip [23] Recommendations graded: A (Category I evidence), B (Category II evidence or extrapolated from category I evidence), C (Category III evidence or extrapolated from category I or II evidence), D (Category IV evidence or extrapolated from category II or III evidence); VAS scale for SOR us”
- CDC guideline for prescribing opioids for chronic pain (2016, background): “Multiple guidelines recommend NSAIDs as first-line pharmacotherapy for osteoarthritis (83-88) or for low back pain (89); however, NSAIDs and COX-2 inhibitors do have gastrointestinal, renal, and cardiovascular risks.”